Open AccessCOVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia
Author(s) -
Balraj Singh,
Sarah Ayad,
Parminder Kaur,
Ro-Jay Reid,
Sachin Gupta,
Michael Maroules
Publication year - 2021
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2021_002348
Subject(s) - medicine , covid-19 , pandemic , coronavirus , respiratory system , disease , immunology , virology , infectious disease (medical specialty) , outbreak
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/?l) in CLL patients.